Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
MCED tests aim to detect multiple cancer types through a single blood test, potentially simplifying cancer screening and expanding detection capabilities. However, their implementation raises critical questions about evidence standards and evaluation methods.
Hematology/Oncology July 29th 2024
Epoch Health
Early ovary removal may lead to abrupt endocrine dysfunction, potentially increasing the risk of cognitive impairment and dementia in women.
Endocrinology, Diabetes, Metabolism July 29th 2024
Oncology News Central (ONC)
PBMs’ vertical integration allows them to dictate cancer treatment decisions, from drug selection to delivery methods, potentially compromising patient care and increasing costs.
The 2024-2025 cancer care rankings incorporate outpatient outcomes and refine criteria for high-risk patient transfers, aiming to provide a more comprehensive evaluation of cancer care quality.
MDLinx
Experts note that the use of chemotherapy can indicate cancer spread beyond its origin, potentially reflecting the stage, aggressiveness, or progression potential of the disease.
Gastroenterology July 24th 2024
Cancer Therapy Advisor
Careful management with endocrinology expertise is crucial when considering radioligand therapy for pheochromocytomas and paragangliomas to avoid potentially life-threatening catecholamine crises.
Endocrinology, Diabetes, Metabolism July 16th 2024